Results 101 to 110 of about 22,260 (249)

Pharmacokinetic, Safety, and Immunogenicity Similarity of High‐ and Low‐Concentration Formulations of Adalimumab Biosimilar ABP 501, Adalimumab‐Atto

Pharmacology Research &Perspectives, Volume 14, Issue 2, April 2026.
Consistent with previously demonstrated similarity of biosimilar ABP 501 (adalimumab‐atto) with adalimumab reference product, this study in healthy adults demonstrates the pharmacokinetic, safety, and immunogenicity similarity of a high‐concentration formulation (100 mg/mL) of ABP 501 with the original 50mg/mL formulation.
Vincent Chow, Muhan Zhou, Daniel T. Mytych, Alexander Colbert, Mieke Jill Miller, Iwona Wala, Ahad Sabet, Waldemar Radziszewski   +7 more
wiley   +1 more source

The ABP Contingency [PDF]

The Behavior Analyst, 1985
openaire   +2 more sources

Development of a C5‐Azidoacetamide‐Modified 4‐Amino‐2,3‐Difluorosialic Acid Activity‐Based Probe for Labeling of Influenza A Neuraminidases

ChemBioChem, Volume 27, Issue 6, 27 March 2026.
We report DFSA5Az/DFSA5bio, C5‐azidoacetamide 4‐amino‐2,3‐difluorosialic acid activity‐based probes that trap influenza A viral (IAV) neuraminidases (NA) via a stabilized covalent Tyr‐sialosyl intermediate with hour‐scale reactivation. A bioorthogonal azide enables CuAAC (or one‐step biotin) tagging for activity‐dependent Western‐blot detection at ...
Lemeng Chao, Erianna I. Alvarado‐Melendez, Katherine Marougka, Xuesheng Wu, Cornelis A. M. de Haan, Karin Strijbis, Tom Wennekes   +6 more
wiley   +1 more source

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ

Vascular Health and Risk Management, 2011
Daniel Duprez1, Keith Ferdinand2, Das Purkayastha3, Rita Samuel3, Richard Wright41University of Minnesota, Minneapolis, MN, 2Atlanta Clinical Research Centers, Atlanta, GA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Pacific Heart Institute,
Duprez D, Ferdinand, Wright
doaj  

Comportamento sexual compulsivo: um transtorno do impulso

Debates em Psiquiatria
Introdução: Na Classificação Internacional de Doenças, 11ª edição (CID-11), o Transtorno do Comportamento Sexual Compulsivo (TCSC) é classificado entre os transtornos mentais, no capítulo Transtornos do Impulso.
Arnaldo Barbieri Filho, Daniel Proença Feijó, Diego Silva de Fraga, Cláudio Meneghello Martins, Carmita Helena Najjar Abdo   +4 more
doaj   +1 more source

APRENDIZAGEM BASEADA EM PROBLEMAS (ABP): RELATO DE UMA EXPERIÊNCIA NO ENSINO DE CIÊNCIAS

, 2021
Mayara Lopes de Freitas Lima, Priscila Aparecida dos Santos Cordeiro, David Gadelha da Costa, Judimar Teixeira da Silva, Viviane Barbosa da Silva, Bruna Kelly Pereira Alves de Souza, Renato Veríssimo de Souza, Ivoneide Mendes da Silva   +7 more
openalex   +2 more sources

The ABP Noncontingency: A Response to “The ABP Contingency” [PDF]

The Behavior Analyst, 1985
openaire   +2 more sources

Retrospectiva 2016 da ABP

Publicações ABP documentos e vídeos = ABP Publications documents and videos, 2016
.
openaire   +1 more source

Unsaturated Phosphorus Electrophiles to Probe Protein Tyrosine Phosphatases

Angewandte Chemie International Edition, Volume 65, Issue 11, 9 March 2026.
Charged aryl‐ethynyl phosphonamidic and phosphonic acids are introduced as low‐reactivity electrophiles for peptide‐based activity probes that enable selective, target‐specific profiling of protein tyrosine phosphatases. The probes show no off‐target cysteine reactivity and engage only the interacting phosphatase in global proteomic analysis.
Eleftheria Poulou, Max Ruwolt, Christian E. Stieger, Kristin Kemnitz‐Hassanin, Christian P. R. Hackenberger   +4 more
wiley   +1 more source

Exercise training and dynamic cerebral autoregulation: Is adaptation possible?

Experimental Physiology, EarlyView.
Patrice Brassard
wiley   +1 more source